APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer
Phase 3 Completed
1,428 enrolled 21 charts
NAVI
Completed
300 enrolled 7 charts
Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV)
Phase NA Completed
188 enrolled 11 charts
Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy
Phase 3 Completed
401 enrolled 14 charts
Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose Melphalan
Phase 3 Completed
52 enrolled 11 charts
CINV
Phase 2 Completed
67 enrolled 12 charts
Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With Cancer
Phase 2/3 Completed
53 enrolled 15 charts
EVOLVE_CINV
Completed
207 enrolled 10 charts
Rolapitant as an Antiemetic in Malignant Glioma Patients Receiving Radiotherapy and Temozolomide
Phase 2 Completed
48 enrolled 25 charts
Promoting Cancer Symptom Management in Older Adults
Phase NA Completed
80 enrolled 11 charts
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Phase 3 Completed
743 enrolled 10 charts
SCUSF1202
Phase NA Completed
187 enrolled 5 charts
Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients
Phase 2/3 Completed
30 enrolled 9 charts
Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation
Phase 3 Completed
76 enrolled 8 charts
Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer
Phase 3 Completed
62 enrolled 15 charts
A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer
Phase 3 Completed
404 enrolled 19 charts
NEXIUM
Phase 3 Terminated
43 enrolled 5 charts
KMEC
Phase 4 Completed
494 enrolled 14 charts
Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer
Phase 2 Completed
22 enrolled 9 charts
Emend and Ondansetron Compared to Ondansetron Alone to Prevent CINV in Glioma Patients Receiving Temozolomide
Phase 2 Completed
136 enrolled 10 charts
An Efficacy and Safety Study of Intravenous Palonosetron Administered as an Infusion and as a Bolus for the Prevention of Nausea and Vomiting
Phase 3 Completed
441 enrolled 20 charts
HDIL2/Emend
Phase 2 Terminated
13 enrolled 7 charts
Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer
Phase NA Terminated
4 enrolled 5 charts
A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.
Phase 3 Completed
710 enrolled 29 charts
Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer
Phase 2 Terminated
7 enrolled 1 chart
Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer
Phase NA Completed
41 enrolled 12 charts
Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX
Phase 2 Completed
54 enrolled 7 charts
Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant
Phase NA Completed
40 enrolled 8 charts
Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By Chemotherapy
Phase 1/2 Terminated
34 enrolled 12 charts
Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting
Phase 4 Completed
20 enrolled 5 charts
The Efficacy of Acupuncture in Treating Chemotherapy Side Effects in Breast Cancer Patients
Phase NA Terminated
10 enrolled 3 charts
Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors
Phase 2 Completed
65 enrolled 14 charts
Fosaprepitant in Patients Receiving Ifosfamide-based Regimen
Phase NA Completed
47 enrolled 6 charts
Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant
Phase NA Completed
40 enrolled 9 charts
Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial
Phase 3 Completed
1,021 enrolled 10 charts
Ginger in Treating Nausea in Patients Receiving Chemotherapy for Cancer
Phase 2/3 Completed
745 enrolled 18 charts
Delayed Nausea and Vomiting in Patients With Colorectal Cancer Receiving Oxaliplatin
Completed
64 enrolled 5 charts
Randomized Trial of the Effectiveness of Topical "ABH Gel" vs. Placebo in Cancer Patients With Nausea
Phase NA Completed
22 enrolled 7 charts
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
Phase 3 Terminated
22 enrolled 9 charts
Ondansetron Versus Aprepitant Plus Ondansetron for Emesis
Phase 2 Completed
100 enrolled 7 charts
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Phase 3 Completed
1,455 enrolled 11 charts
A Pilot Study of Dronabinol for Adult Patients With Primary Gliomas
Phase 1 Completed
33 enrolled 9 charts
Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)
Phase NA Completed
51 enrolled 5 charts
Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/Carboplatin
Phase 2 Completed
89 enrolled 7 charts
Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting
Phase 1/2 Completed
30 enrolled 4 charts
Ondansetron Plus Dexamethasone With or Without Metoclopramide as Antiemetic Prophylaxis After Receiving Cisplatin
Phase NA Completed
162 enrolled 5 charts